TNF and glioblastoma: So far, several mechanisms have been found to facilitate phenotypic transitions in GBM, and especially enhancement of the mesenchymal phenotype, such as the TGF-β family [53], TNF-α [24], a hypoxic environment [54], and exogenous therapies [55].